SEC Form 4 · accession 0001038133-16-000331
HESKA CORP · HSKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rod Lippincott
Officer — EVP, Comp. Animal Health Sales
Period of report
Nov 22, 2016
Accepted (ET)
Nov 23, 2016 · 10:40 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001038133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 22, 2016 | M | 2,000 | $18.13 | A | 10,192 | D | |
| Common Stock | Nov 22, 2016 | M | 3,000 | $7.36 | A | 13,192 | D | |
| Common StockF1 | Nov 22, 2016 | S | 5,000 | $64.8515 | D | 8,192 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $7.36 | Nov 22, 2016 | M | 3,000 | D | Nov 21, 2013 | Nov 20, 2023 | Common Stock | 3,000 | 6,425 | D |
| Incentive Stock Option (right to buy) | $18.13 | Nov 22, 2016 | M | 2,000 | D | Dec 31, 2014 | Dec 30, 2024 | Common Stock | 2,000 | 9,000 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from a low of $64.58 to a high of $65.26 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.